Zuvotolimod
Zuvotolimod is a myeloid cell agonist compound-linker for antibody conjugate. Zuvotolimod can be used in the research of cancer and hepatitis[1][2].
Product Specifications
CAS Number
2355262-97-2
UNSPSC
12352203
Target
ADC Linker
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zuvotolimod.html
Purity
99.46
Solubility
10 mM in DMSO
Smiles
O=C(N1CC(C=C(NC(C2=CC3=C(C=C(C(N(CCC)CCC)=O)CC(N)=N3)C=C2)=O)C=N4)=C4CC1)OCC5=CC=C(NC([C@](NC([C@@](C(C)C)([H])NC(CCCCCN6C(C=CC6=O)=O)=O)=O)([H])CCCNC(N)=O)=O)C=C5
Molecular Formula
C55H70N12O10
Molecular Weight
1059.22
References & Citations
[1]Peter Armstrong Thompson, et al. Anti-liver cell or viral antigen antibody conjugate with myeloid cell agonist for treatment of hepatitis. Patent WO2019118884 A1.|[2] Sean Wesley Smith, et al. Preparation of benzazepines and their conjugates containing peptidyl linkers for the treatment of cancer and modulation of TLR8. Patent WO2020056194 A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880525-100 1x 100 µL
CD63 (MX-49.129.5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040257-100 1x 100 µL
Cytokeratin, HMW (AE-3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details